Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1758-1768

  Roti, Michelle ^a   Yang, Junbao ^a   Berger, DeAnna ^a   Huston, Laurie ^a   James, Eddie A ^a   Kwok, William W ^a,b,c  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINTREDEKIN BESUDOTOX; CROSS REACTING ANTIBODY; EPITOPE; GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 5; MATRIX PROTEIN; NUCLEOPROTEIN; SIALIDASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CAUCASIAN; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CROSS REACTION; EX VIVO STUDY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS INFECTION; CHEMISTRY; FEMALE; IMMUNOLOGY; INFLUENZA; MALE; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; FEMALE; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MOLECULAR SEQUENCE DATA; VIRAL PROTEINS;

EID: 40749139110     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1758     Document Type: Article

References (33)

1. Olsen, B., V. J. Munster, A. Wallensten, J. Waldenstrom, A. D. Osterhaus, and R. A. Fouchier. 2006. Global patterns of influenza a virus in wild birds. Science 312: 384-388.
2. Webster, R. G., M. Peiris, H. Chen, and Y. Guan. 2006. H5N1 outbreaks and enzootic influenza. Emerg. Infect. Dis. 12: 3-8.
3. Woo, P. C., S. K. Lau, and K. Y. Yuen. 2006. Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections. Curr. Opin. Infect. Dis. 19: 401-407.
4. Beigel, J. H., J. Farrar, A. M. Han, F. G. Hayden, R. Hyer, M. D. de Jong, S. Lochindarat, T. K. Nguyen, T. H. Nguyen, T. H. Tran, et al. 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353: 1374-1385.
5. Wong, S. S., and K. Y. Yuen. 2006. Avian influenza virus infections in humans. Chest 129: 156-168.
6. de Jong, M. D., and T. T. Hien. 2006. Avian influenza A (H5N1). J. Clin. Virol. 35: 2-13.
7. Webby, R. J., and R. G. Webster. 2003. Are we ready for pandemic influenza? Science 302: 1519-1522.
8. Fauci, A. S. 2006. Pandemic influenza threat and preparedness. Emerg. Infect. Dis. 12: 73-77.
9. Schafer, J. R., Y. Kawaoka, W. J. Bean, J. Suss, D. Senne, and R. G. Webster. 1993. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194: 781-788.
10. Govorkova, E. A., J. E. Rehg, S. Krauss, H. L. Yen, Y. Guan, M. Peiris, T. D. Nguyen, T. H. Hanh, P. Puthavathana, H. T. Long, et al. 2005. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 79: 2191-2198.
11. Maines, T. R., X. H. Lu, S. M. Erb, L. Edwards, J. Guarner, P. W. Greer, D. C. Nguyen, K. J. Szretter, L. M. Chen, P. Thawatsupha, et al. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79: 11788-11800.
12. + T cell responses directed against influenza viral antigens postinfluenza vaccination. J. Immunol. 171: 3163-3169.
13. + T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104: R63-R67.
14. + T cell epitopes from complex antigens. J. Immunol. 166: 6665-6670.
15. Kwok, W. W., J. A. Gebe, A. Liu, S. Agar, N. Ptacek, J. Hammer, D. M. Koelle, and G. T. Nepom. 2001. Rapid epitope identification from complex class-II-restricted T-cell antigens. Trends Immunol. 22: 583-588.
16. + T cells with optimized HLA class II tetramer staining. J. Immunol. 175: 6334-6343.
17. World Health Organization. 1980. A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull. W. H. O. 58: 585-591.
18. Webster, R. G., W. G. Laver, G. M. Air, and G. C. Schild. 1982. Molecular mechanisms of variation in influenza viruses. Nature 296: 115-121.
19. Air, G. M. 1981. Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc. Natl. Acad. Sci. USA 78: 7639-7643.
20. Fouchier, R. A., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. Osterhaus. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79: 2814-2822.
21. + T lymphocyte memory to influenza A viruses of swine and avian species. J. Immunol. 162: 7578-7583.
22. + T lymphocytes. J. Immunol. 172: 2453-2460.
23. Bui, H. H., B. Peters, E. Assarsson, I. Mbawuike, and A. Sette. 2007. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc. Natl. Acad. Sci. USA 104: 246-251.
24. Thomas, P. G., R. Keating, D. J. Hulse-Post, and P. C. Doherty. 2006. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12: 48-54.
25. + T cells in protective immunity to influenza. Immunol. Rev. 211: 8-22.
26. Seo, S. H., and R. G. Webster. 2001. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J. Virol. 75: 2516-2525.
27. -/- respiratory epithelium. J. Virol. 70: 1288-1291.
28. + T-cell activities that enhance the therapeutic activity of antiviral antibodies. J. Virol. 79: 5943-5951.
29. Brown, D. M., A. M. Dilzer, D. L. Meents, and S. L. Swain. 2006. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol. 177: 2888-2898.
30. Epstein, S. L. 2006. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 193: 49-53.
31. World Health Organization. 2006. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly. Epidemiol. Rec. 81: 249-257.
32. World Health Organization. 2007. Update: WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly. Epidemiol. Rec. 82: 41-48.
33. Sandbulte, M. R., G. S. Jimenez, A. C. Boon, L. R. Smith, J. J. Treanor, and R. J. Webby. 2007. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med. 4: e59.